U-M Ranks in Top 10 Global Universities for Oncology Research by U.S. News & World Report
U-M ranks No 9. for oncology research among 1,500 institutions across the globe.
U-M ranks No 9. for oncology research among 1,500 institutions across the globe.
Pooja Lagisetty, MD talks with Everyday Health about the challenges providers and patients face in order to prescribe and get access to buprenorphine.
John Carethers, MD, featured in JCI Insight, discusses disparities in COVID-19 infection and outcome in ethnically diverse groups and considerations that should be taken to rectify this disparity going forward.
Brahmajee Nallamothu, MD and Ji Zhu, BSc (UM Statistics) win the American Heart Association COVID-19 Data Challenge for their analysis of national data for risk factors of COVID-19 infection.
Bethany Moore, PhD breaks down how the COVID-19 vaccine gets to work once it enters the body.
Adam Lauring, MD, PhD speaks with The New York Times about how to protect yourself from the B.1.1.7 Coronavirus variant.
Charles Schuler, IV, MD investigates the how and why of food allergies to develop new diagnostic modalities and therapies to improve patients’ quality of life.
Lillian Min, MD, MSHS leads a study in JAMA Network on better ways of tracking and improving how older adults are being treated for hypertension.
Vincent Young, MD, PhD publishes paper on findings of prenatal exposure to microbes.
Meilan Han MD, MS speaks with Parade Magazine on Pneumonia.
Michigan labs are actively sequencing genetic material from positive COVID-19 test samples to see if the variant is present.
Follicular lymphoma-associated BTK mutations are inactivating resulting in augmented AKT activation
Ramadan Ali, PhD and Jason Knight, MD, PhD find the main bioactive compound in ginger lowers autoantibody production and helps halt disease progression in mice with APS and lupus.
Eve Kerr MD, MPH, is taking over for the esteemed Laurence McMahon, MD, MPH who will be stepping down from the role beginning on March 1.
Ajjai Alva MD, and Dan Robinson PhD, (U-M Pathology) were awarded the 2020 Bristol-Myers Squibb-PCF Challenge Award to investigate the efficacy and mechanisms by which checkpoint immunotherapy may work in CDK12-mutant prostate cancer.
John M. Carethers, MD discusses the similar disparities occurring in cancer and COVID-19 in paper published by Clinical Cancer Research.